Sorin and Cyberonics have signed a definitive merger agreement, in furtherance of the merger plan unanimously approved by their boards of directors.
The transaction remains subject to certain conditions including, without limitation: approval by both Sorin and Cyberonics’ shareholders, the receipt of required antitrust and regulatory clearances, and other customary closing conditions.
The combination of Sorin and Cyberonics will create a new global medical technology company. This merger is expected to drive significant value for shareholders by “leveraging combined strengths, capturing new opportunities and creating new solutions to benefit patients and healthcare professionals alike and is particularly exciting for employees, who will be able to share technical expertise and innovate faster”, according to a company press release.
